Cooper Companies Inc (COO) Director Sells $100,761.90 in Stock

Share on StockTwits

Cooper Companies Inc (NYSE:COO) Director Gary S. Petersmeyer sold 430 shares of the business’s stock in a transaction that occurred on Friday, June 22nd. The stock was sold at an average price of $234.33, for a total transaction of $100,761.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Shares of Cooper Companies stock opened at $234.00 on Tuesday. The firm has a market capitalization of $11.65 billion, a PE ratio of 21.68, a price-to-earnings-growth ratio of 1.87 and a beta of 0.61. Cooper Companies Inc has a 12 month low of $216.47 and a 12 month high of $260.26. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 2.76.

Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, June 7th. The medical device company reported $2.86 EPS for the quarter, beating analysts’ consensus estimates of $2.84 by $0.02. The business had revenue of $631.30 million for the quarter, compared to analysts’ expectations of $627.49 million. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. The company’s quarterly revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the company posted $2.50 EPS. equities research analysts expect that Cooper Companies Inc will post 11.81 EPS for the current fiscal year.

Several brokerages have recently weighed in on COO. TheStreet downgraded shares of Cooper Companies from a “b” rating to a “c” rating in a research report on Thursday, March 8th. BMO Capital Markets restated an “outperform” rating and set a $280.00 price objective (up previously from $277.00) on shares of Cooper Companies in a research report on Friday, March 9th. Oppenheimer set a $265.00 price objective on shares of Cooper Companies and gave the stock a “hold” rating in a research report on Friday, March 9th. Stephens restated a “hold” rating and set a $270.00 price objective on shares of Cooper Companies in a research report on Friday, March 9th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $285.00 target price on shares of Cooper Companies in a report on Friday, March 9th. Ten investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Cooper Companies presently has an average rating of “Hold” and a consensus target price of $265.36.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Mount Yale Investment Advisors LLC acquired a new position in Cooper Companies in the 1st quarter valued at $422,000. Suntrust Banks Inc. increased its stake in Cooper Companies by 30.4% in the 1st quarter. Suntrust Banks Inc. now owns 2,667 shares of the medical device company’s stock valued at $609,000 after buying an additional 621 shares during the period. Redwood Investments LLC acquired a new position in Cooper Companies in the 1st quarter valued at $3,673,000. Allianz Asset Management GmbH increased its stake in Cooper Companies by 36.5% in the 1st quarter. Allianz Asset Management GmbH now owns 202,613 shares of the medical device company’s stock valued at $46,359,000 after buying an additional 54,143 shares during the period. Finally, Amalgamated Bank increased its stake in Cooper Companies by 4.8% in the 1st quarter. Amalgamated Bank now owns 10,845 shares of the medical device company’s stock valued at $2,481,000 after buying an additional 493 shares during the period. 96.85% of the stock is currently owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.